Our Pricing

Orlistat vs Mounjaro: Next Day Delivery Across UK

Published on: June 03, 2026

Choosing between orlistat vs mounjaro uk next day delivery options depends on your weight loss goals, medical history, and treatment preferences. At Cured Pharmacy, our UK-registered clinical team helps you access both treatments with transparent upfront pricing, free consultations under 3 minutes, and discreet next-day delivery across the UK.

How Orlistat and Mounjaro Work Differently

Orlistat and Mounjaro represent fundamentally different approaches to weight management, each targeting distinct biological pathways. Orlistat (available as generic capsules, Xenical, Alli, and Orlos) works locally in your digestive system by blocking approximately 30% of dietary fat absorption [1]. The unabsorbed fat passes through your system naturally, reducing overall calorie intake from meals. This mechanism requires no systemic absorption and begins working with your very first dose.

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [2]. Unlike Orlistat's digestive action, tirzepatide works systemically by activating two natural hormone pathways that regulate blood sugar, slow gastric emptying, and reduce appetite signals to the brain. In the SURPASS-3 trial, patients achieved an average 22.5% total body weight reduction over 72 weeks on the highest maintenance dose [2].

The practical difference matters: Orlistat requires you to modify fat intake and take capsules three times daily with meals, whilst Mounjaro involves a single weekly subcutaneous injection with no specific dietary fat restrictions. Both treatments require ongoing lifestyle modifications including reduced calorie intake and increased physical activity for optimal results [1][2].

Clinical Effectiveness: What the Trials Show

Head-to-head clinical data directly comparing Orlistat and Mounjaro doesn't exist, but individual trial results provide clear benchmarks. In a comprehensive meta-analysis of Orlistat trials, patients achieved an average 2.9 kg greater weight loss compared to placebo over 12 months when combined with reduced-calorie diets [1]. Most patients using Orlistat 120mg three times daily can expect approximately 5-10% total body weight reduction over one year, subject to adherence and lifestyle factors.

Mounjaro demonstrates substantially greater weight reduction in clinical trials. The SURMOUNT-1 study showed average reductions of 15.0% (5mg dose), 19.5% (10mg dose), and 20.9% (15mg maintenance dose) over 72 weeks in adults without diabetes [3]. These results significantly exceed those seen with earlier GLP-1 treatments and represent the highest average weight loss observed in any obesity medication trial to date.

Your UK prescriber will consider these efficacy differences alongside your baseline BMI, comorbidities, previous treatment responses, and personal preferences. Patients seeking modest weight reduction with lower treatment costs often find Orlistat suitable, whilst those requiring greater weight loss or managing type 2 diabetes may benefit more from Mounjaro, subject to clinical assessment and prescriber approval [1][3].

Long-Term Weight Maintenance

Both medications require ongoing use to maintain weight loss. Clinical data shows that discontinuing either treatment typically results in gradual weight regain unless lifestyle modifications are sustained [1][3]. Your prescriber will discuss realistic expectations for long-term treatment and the importance of behavioural changes that extend beyond medication alone.

Side Effect Profiles and Tolerability

Orlistat's side effects relate directly to its mechanism of blocking fat absorption. The most common effects include oily spotting, flatulence with discharge, urgent bowel movements, and fatty or oily stools, particularly when consuming meals high in fat [1]. These gastrointestinal effects occur in up to 20-30% of patients but can be minimised by limiting dietary fat to approximately 15g per meal. Most patients find these effects decrease over the first few weeks as they adapt their eating patterns.

Mounjaro's side effect profile differs considerably. The most frequently reported effects are gastrointestinal—nausea (occurring in approximately 12-22% of patients), diarrhoea, vomiting, constipation, and abdominal discomfort—typically most pronounced during dose escalation periods [2][3]. These effects usually diminish over 4-8 weeks as your body adjusts to each dose level. Rare but serious risks include pancreatitis, gallbladder disease, and thyroid C-cell tumours observed in rodent studies, though human relevance remains uncertain.

Your UK prescriber will review your complete medical history during consultation. Orlistat is contraindicated in chronic malabsorption syndrome and cholestasis, whilst Mounjaro should not be used in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [1][2]. Both treatments require careful consideration in patients taking other medications, particularly anticoagulants, antidiabetic drugs, or immunosuppressants.

Managing Side Effects Effectively

With Orlistat, distributing fat intake evenly across meals and choosing lean proteins helps minimise digestive effects. For Mounjaro, eating smaller portions, avoiding high-fat meals, and staying well-hydrated typically reduces nausea. Your prescriber can adjust dosing schedules if side effects prove problematic, and our clinical team remains available for ongoing support throughout your treatment journey.

Orlistat vs Mounjaro: Cost and Value Considerations

Treatment costs represent a significant factor for most patients pursuing long-term weight management. At Cured Pharmacy, Orlistat starts from £135.00 for generic capsules, with branded options including Xenical from £135.00, Alli 60mg from £135.00, and Orlos 60mg from £135.00. These prices reflect monthly supply costs, making Orlistat one of the most affordable prescription weight loss treatments available in the UK.

Mounjaro pricing reflects its advanced dual-agonist formulation and greater clinical efficacy, starting from £124.99 per month at Cured Pharmacy. Whilst the upfront cost exceeds Orlistat, many patients find the greater average weight loss and once-weekly administration justify the investment. Your final cost depends on your prescribed maintenance dose, which your UK prescriber determines based on your response and tolerability during the initial titration period.

Cost-effectiveness extends beyond the price per month. Consider the total treatment duration needed to reach your goal weight, the likelihood of achieving and maintaining that goal, and the potential health benefits of greater weight reduction on conditions like type 2 diabetes, hypertension, and sleep apnoea. Our superintendent pharmacist Tarun Kumar and clinical team ensure you receive transparent pricing information before any consultation commitment, with no hidden fees or surprise charges.

Who Should Choose Orlistat vs Mounjaro?

Orlistat suits patients seeking a non-systemic, tablet-based approach who are comfortable with three-times-daily dosing and willing to modify dietary fat intake. It's particularly appropriate for individuals with BMI ≥30 kg/m² (or ≥28 kg/m² with weight-related comorbidities) who prefer avoiding injections, have contraindications to GLP-1 treatments, or require the most cost-effective prescription option [1]. Orlistat also works well for patients who've previously succeeded with structured meal planning and benefit from the immediate feedback mechanism its side effects provide when consuming high-fat foods.

Mounjaro typically suits patients requiring greater weight reduction, those managing type 2 diabetes alongside obesity, or individuals who've had insufficient results with previous treatments including Orlistat [2][3]. The once-weekly injection appeals to patients seeking maximum convenience, and the dual GIP/GLP-1 mechanism provides additional metabolic benefits beyond weight loss alone. Clinical trials demonstrate particular effectiveness in patients with baseline BMI ≥30 kg/m² and those with obesity-related complications requiring substantial weight reduction.

Your UK prescriber will conduct a comprehensive assessment considering your BMI, medical history, current medications, weight loss goals, lifestyle factors, and treatment preferences. Both medications require prescription approval and ongoing clinical monitoring. At Cured Pharmacy, our consultation process takes under 3 minutes, with prescriber review typically completed the same day, subject to clinical suitability and prescriber availability.

Combination and Sequential Approaches

Some patients begin with Orlistat to establish lifestyle modifications before progressing to Mounjaro if additional weight loss is needed. Others may use Mounjaro to achieve initial substantial weight reduction, then transition to maintenance strategies. Your prescriber will discuss the most appropriate pathway for your individual circumstances, with regular reviews to assess progress and adjust treatment as needed.

Getting Started: Next Day Delivery Across the UK

Accessing either treatment through Cured Pharmacy begins with our free online consultation, completed in under 3 minutes from any device. You'll answer questions about your medical history, current medications, weight loss goals, and previous treatment attempts. Our UK-registered prescribers review every consultation individually—there are no automatic approvals or algorithm-based decisions.

Once your prescriber approves your treatment (subject to clinical suitability), our registered pharmacy team dispenses your medication the same day in most cases. We offer next-day delivery across the UK in discreet, unmarked packaging with no indication of contents. All medications are genuine UK-licensed products sourced through regulated wholesalers—we never supply unlicensed imports or compounded alternatives.

Your treatment includes ongoing support from our clinical team. We provide clear administration instructions for Mounjaro injections or dosing guidance for Orlistat capsules, advice on managing potential side effects, and access to our pharmacist team on (+44) 116 4646009 during business hours. Regular follow-up consultations ensure your treatment remains appropriate, effective, and safe throughout your weight loss journey.

Cured Pharmacy operates under GPhC registration number 9012511, with superintendent pharmacist Tarun Kumar (GPhC 2233073) overseeing all clinical services. We guarantee the lowest prices in the UK on all weight loss treatments, with transparent upfront pricing displayed before you begin any consultation. Start your free assessment today to discover which treatment suits your needs.

Scientific References

1. Rucker, D., Padwal, R., Li, S. K., Curioni, C., & Lau, D. C. (2007). Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ, 335(7631), 1194–1199. https://doi.org/10.1136/bmj.39385.413113.25 [accessed 13 August 2026]
2. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, dietary modifications, and lifestyle factors. Past clinical trial results do not guarantee individual outcomes.